CoChat

Clodronate-nintedanib-loaded exosome–liposome hybridization enhances the liver fibrosis therapy by inhibiting Kupffer cell activity

Ji, Keqin, Fan, Mingrui, Huang, Dong, Sun, Lingna, Li, Bingqin, Xu, Ruoting, Zhang, Jiajing, Shao, Xuan, Chen, Yanzuo · 2022 · Biomaterials Science
Cited by 41

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

CLD/NIN@LIEV decreases the nonspecific phagocytosis of nanoparticles and suppresses the inflammatory cytokines secreted by Kupffer cells, thus enhancing the therapeutic effects against liver fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1039/d1bm01663f

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 24

  1. Seniutkin, 2018, Toxicol. Appl. Pharmacol., 339, 1, 10.1016/j.taap.2017.11.024 · DOI
  2. Berumen, 2021, Wiley Interdiscip. Rev.: Syst. Biol. Med., 13, e1499, 10.1002/wics.1499 · DOI
  3. Koyama, 2019, Am. J. Respir. Cell Mol. Biol., 60, 478, 10.1165/rcmb.2018-0098OC · DOI
  4. Mohammadalipour, 2019, Clin. Exp. Pharmacol. Physiol., 46, 1183, 10.1111/1440-1681.13157 · DOI
  5. Varone, 2018, Expert Opin. Pharmacother., 19, 167, 10.1080/14656566.2018.1425681 · DOI
  6. Wollin, 2020, BioMed Res. Int., 2020, 3867198, 10.1155/2020/3867198 · DOI
  7. Feng, 2021, Kidney Dis., 7, 34, 10.1159/000509670 · DOI
  8. Cai, 2018, J. Cell. Mol. Med., 22, 5050, 10.1111/jcmm.13787 · DOI · Paper page
  9. Roth, 2015, J. Med. Chem., 58, 1053, 10.1021/jm501562a · DOI · Paper page
  10. Aghebati-Maleki, 2020, J. Cell Physiol., 235, 1962, 10.1002/jcp.29126 · DOI · Paper page
  11. Peng, 2021, Biomed. Pharmacother., 137, 111342, 10.1016/j.biopha.2021.111342 · DOI · Paper page
  12. Luo, 2019, ACS Nano, 13, 3910, 10.1021/acsnano.8b06924 · DOI · Paper page
  13. Qiao, 2020, J. Controlled Release, 321, 629, 10.1016/j.jconrel.2020.02.049 · DOI · Paper page
  14. Lin, 2016, J. Controlled Release, 221, 62, 10.1016/j.jconrel.2015.11.003 · DOI
  15. Giannitrapani, 2014, World J. Gastroenterol., 20, 7242, 10.3748/wjg.v20.i23.7242 · DOI · Paper page
  16. Kuznik, 2020, Eur. J. Pharmacol., 866, 172773, 10.1016/j.ejphar.2019.172773 · DOI
  17. van Rooijen, 2010, Methods Mol. Biol., 605, 189, 10.1007/978-1-60327-360-2_13 · DOI · Paper page
  18. Sun, 2021, Biomaterials, 271, 120761, 10.1016/j.biomaterials.2021.120761 · DOI · Paper page
  19. Poelstra, 2011, J. Hepatol., 55, 726, 10.1016/j.jhep.2011.04.008 · DOI · Paper page
  20. Iwakiri, 2014, J. Hepatol., 61, 912, 10.1016/j.jhep.2014.05.047 · DOI · Paper page
  21. Tsochatzis, 2008, Aliment. Pharmacol. Ther., 27, 80, 10.1111/j.1365-2036.2007.03538.x · DOI
  22. Kooijmans, 2017, Nat. Biomed. Eng., 1, 634, 10.1038/s41551-017-0119-4 · DOI
  23. Fallatah, 2016, Hepatitis Mon., 16, e38346
  24. Shrestha, 2016, Food Chem. Toxicol., 93, 129, 10.1016/j.fct.2016.04.024 · DOI

Cited by

See all 41

Metadata

Authors
Ji, K., Fan, M., Huang, D., Sun, L., Li, B., Xu, R., Zhang, J., Shao, X., & Chen, Y.
Venue
Biomaterials Science
Published
2022
Volume
10
Issue
3
Pages
702-713
ISSN
  • 2047-4830 (ISSN-L)
  • 2047-4849
OpenAlex
W4200247641
Cited by
41
References
12
FWCI
3.16
Type
journal article
Language
en
Open access
closed
Funders
Natural Science Foundation of Shanghai (19ZR1472500)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clodronate-nintedanib-loaded exosome–liposome hybridization enhances the liver fibrosis therapy by inhibiting Kupffer cell activity. https://app.cochat.ai/papers/10.1039/d1bm01663f
The paper
Ji, K., Fan, M., Huang, D., Sun, L., Li, B., Xu, R., Zhang, J., Shao, X., & Chen, Y. (2022). Clodronate-nintedanib-loaded exosome–liposome hybridization enhances the liver fibrosis therapy by inhibiting Kupffer cell activity. Biomaterials Science. https://doi.org/10.1039/d1bm01663f

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.